General MedicationsORALGeneric
JESDUVROQ
DAPRODUSTAT
Standard Dose
6MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview JESDUVROQ is listed in Drugs@FDA under application 216951 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient DAPRODUSTAT Form and strength TABLET;ORAL - 6MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2023-02-01 00:00:00.
Structured Monograph
Clinical summary
Approval overview JESDUVROQ is listed in Drugs@FDA under application 216951 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DAPRODUSTAT Form and strength TABLET;ORAL - 6MG Sponsor GLAXOSMITHKLINE Submission history Latest submission status date: 2023-02-01 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.